Gong, L., Yang, J. Y., Aswani, N., Park, J., Hur, C. (2026). Early identification of patients at risk for moderate-to-severe immunotherapy-related adverse events following immune checkpoint inhibitor therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13695